トゥレット症候群治療薬の世界市場 2024-2028

トゥレット症候群治療薬市場は2023-2028年に6億4,210万米ドル、予測期間中のCAGRは6.78％で成長すると予測されます。

当レポートでは、トゥレット症候群治療薬市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、トゥレット症候群に対する認識の高まり、世界中でトゥレット症候群の症例が増加していること、費用対効果の高い治療に対する需要が高まっていることなどが牽引しています。

本調査では、今後数年間のトゥレット症候群治療薬市場成長を牽引する主要因の1つとして、トゥレット症候群に対する研究開発投資の増加を挙げています。また、ベンダー間の戦略的提携の高まりやヘルスケアインフラ支出の増加は、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム
• 市場の特徴
• バリューチェーン分析

第3章 市場規模の評価

• 市場の定義
• 市場セグメント分析
• 市場規模 2023
• 市場の見通し 2023-2028

第4章 市場規模実績

• トゥレット症候群治療薬の世界市場 2018-2022
• 製品別セグメント分析 2018-2022
• 流通チャネル別セグメント分析 2018-2022
• 地域別セグメント分析 2018-2022
• 国別セグメント分析 2018-2022

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：製品別

• 市場セグメンテーション
• 比較：製品別
• 抗精神病薬：市場規模と予測 2023-2028
• 非抗精神病薬：市場規模と予測 2023-2028
• 市場機会：製品別

第7章 市場セグメンテーション：流通チャネル別

• 市場セグメンテーション
• 比較：流通チャネル別
• オフライン：市場規模と予測 2023-2028
• オンライン：市場規模と予測 2023-2028
• 市場機会：流通チャネル別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2023-2028
• 欧州：市場規模と予測 2023-2028
• アジア：市場規模と予測 2023-2028
• 世界のその他の地域：市場規模と予測 2023-2028
• 米国：市場規模と予測 2023-2028
• ドイツ：市場規模と予測 2023-2028
• 英国：市場規模と予測 2023-2028
• 中国：市場規模と予測 2023-2028
• カナダ：市場規模と予測 2023-2028
• 市場機会：地域情勢別

第10章 促進要因・課題・機会・抑制要因

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場の機会・抑制要因

第11章 競合情勢

• 概要
• 競合情勢
• 混乱の状況
• 業界のリスク

第12章 競合分析

• 企業プロファイル
• 企業の市場ポジショニング
• AstraZeneca Plc
• Bausch Health Companies Inc.
• Catalyst Pharmaceuticals Inc
• Eli Lilly and Co.
• Emalex Biosciences Inc.
• H Lundbeck AS
• Johnson and Johnson Services Inc.
• Medtronic Plc
• Neurocrine Biosciences Inc.
• Otsuka Holdings Co. Ltd.
• Paragon Biosciences LLC
• Questex LLC
• Reviva Pharmaceuticals Holdings Inc
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Product
• Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Company Market Positioning
• Exhibits10: Parent Market
• Exhibits11: Data Table on - Parent Market
• Exhibits12: Market characteristics analysis
• Exhibits13: Value Chain Analysis
• Exhibits14: Offerings of companies included in the market definition
• Exhibits15: Market segments
• Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits20: Historic Market Size - Data Table on Global Tourettes Syndrome Drugs Market 2018 - 2022 ($ million)
• Exhibits21: Historic Market Size - Product Segment 2018 - 2022 ($ million)
• Exhibits22: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
• Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• Exhibits25: Five forces analysis - Comparison between 2023 and 2028
• Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits31: Chart on Market condition - Five forces 2023 and 2028
• Exhibits32: Chart on Product - Market share 2023-2028 (%)
• Exhibits33: Data Table on Product - Market share 2023-2028 (%)
• Exhibits34: Chart on Comparison by Product
• Exhibits35: Data Table on Comparison by Product
• Exhibits36: Chart on Antipsychotics - Market size and forecast 2023-2028 ($ million)
• Exhibits37: Data Table on Antipsychotics - Market size and forecast 2023-2028 ($ million)
• Exhibits38: Chart on Antipsychotics - Year-over-year growth 2023-2028 (%)
• Exhibits39: Data Table on Antipsychotics - Year-over-year growth 2023-2028 (%)
• Exhibits40: Chart on Non-antipsychotics - Market size and forecast 2023-2028 ($ million)
• Exhibits41: Data Table on Non-antipsychotics - Market size and forecast 2023-2028 ($ million)
• Exhibits42: Chart on Non-antipsychotics - Year-over-year growth 2023-2028 (%)
• Exhibits43: Data Table on Non-antipsychotics - Year-over-year growth 2023-2028 (%)
• Exhibits44: Market opportunity by Product ($ million)
• Exhibits45: Data Table on Market opportunity by Product ($ million)
• Exhibits46: Chart on Distribution Channel - Market share 2023-2028 (%)
• Exhibits47: Data Table on Distribution Channel - Market share 2023-2028 (%)
• Exhibits48: Chart on Comparison by Distribution Channel
• Exhibits49: Data Table on Comparison by Distribution Channel
• Exhibits50: Chart on Offline - Market size and forecast 2023-2028 ($ million)
• Exhibits51: Data Table on Offline - Market size and forecast 2023-2028 ($ million)
• Exhibits52: Chart on Offline - Year-over-year growth 2023-2028 (%)
• Exhibits53: Data Table on Offline - Year-over-year growth 2023-2028 (%)
• Exhibits54: Chart on Online - Market size and forecast 2023-2028 ($ million)
• Exhibits55: Data Table on Online - Market size and forecast 2023-2028 ($ million)
• Exhibits56: Chart on Online - Year-over-year growth 2023-2028 (%)
• Exhibits57: Data Table on Online - Year-over-year growth 2023-2028 (%)
• Exhibits58: Market opportunity by Distribution Channel ($ million)
• Exhibits59: Data Table on Market opportunity by Distribution Channel ($ million)
• Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits61: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits62: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits63: Chart on Geographic comparison
• Exhibits64: Data Table on Geographic comparison
• Exhibits65: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits66: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits67: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits68: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits69: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits70: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits71: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits72: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits73: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits74: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits75: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits76: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits77: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits78: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits79: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits80: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits81: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibits82: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibits83: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits84: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits85: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits86: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits87: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits88: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits89: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits90: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits91: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibits92: Data Table on UK - Year-over-year growth 2023-2028 (%)
• Exhibits93: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibits94: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibits95: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibits96: Data Table on China - Year-over-year growth 2023-2028 (%)
• Exhibits97: Chart on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibits98: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibits99: Chart on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits100: Data Table on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits101: Market opportunity By Geographical Landscape ($ million)
• Exhibits102: Data Tables on Market opportunity By Geographical Landscape ($ million)
• Exhibits103: Impact of drivers and challenges in 2023 and 2028
• Exhibits104: Overview on criticality of inputs and factors of differentiation
• Exhibits105: Overview on factors of disruption
• Exhibits106: Impact of key risks on business
• Exhibits107: Companies covered
• Exhibits108: Matrix on companies position and classification
• Exhibits109: AstraZeneca Plc - Overview
• Exhibits110: AstraZeneca Plc - Product / Service
• Exhibits111: AstraZeneca Plc - Key news
• Exhibits112: AstraZeneca Plc - Key offerings
• Exhibits113: Bausch Health Companies Inc. - Overview
• Exhibits114: Bausch Health Companies Inc. - Business segments
• Exhibits115: Bausch Health Companies Inc. - Key news
• Exhibits116: Bausch Health Companies Inc. - Key offerings
• Exhibits117: Bausch Health Companies Inc. - Segment focus
• Exhibits118: Catalyst Pharmaceuticals Inc - Overview
• Exhibits119: Catalyst Pharmaceuticals Inc - Product / Service
• Exhibits120: Catalyst Pharmaceuticals Inc - Key offerings
• Exhibits121: Eli Lilly and Co. - Overview
• Exhibits122: Eli Lilly and Co. - Product / Service
• Exhibits123: Eli Lilly and Co. - Key news
• Exhibits124: Eli Lilly and Co. - Key offerings
• Exhibits125: Emalex Biosciences Inc. - Overview
• Exhibits126: Emalex Biosciences Inc. - Product / Service
• Exhibits127: Emalex Biosciences Inc. - Key offerings
• Exhibits128: H Lundbeck AS - Overview
• Exhibits129: H Lundbeck AS - Product / Service
• Exhibits130: H Lundbeck AS - Key offerings
• Exhibits131: Johnson and Johnson Services Inc. - Overview
• Exhibits132: Johnson and Johnson Services Inc. - Business segments
• Exhibits133: Johnson and Johnson Services Inc. - Key news
• Exhibits134: Johnson and Johnson Services Inc. - Key offerings
• Exhibits135: Johnson and Johnson Services Inc. - Segment focus
• Exhibits136: Medtronic Plc - Overview
• Exhibits137: Medtronic Plc - Business segments
• Exhibits138: Medtronic Plc - Key news
• Exhibits139: Medtronic Plc - Key offerings
• Exhibits140: Medtronic Plc - Segment focus
• Exhibits141: Neurocrine Biosciences Inc. - Overview
• Exhibits142: Neurocrine Biosciences Inc. - Product / Service
• Exhibits143: Neurocrine Biosciences Inc. - Key offerings
• Exhibits144: Otsuka Holdings Co. Ltd. - Overview
• Exhibits145: Otsuka Holdings Co. Ltd. - Business segments
• Exhibits146: Otsuka Holdings Co. Ltd. - Key news
• Exhibits147: Otsuka Holdings Co. Ltd. - Key offerings
• Exhibits148: Otsuka Holdings Co. Ltd. - Segment focus
• Exhibits149: Paragon Biosciences LLC - Overview
• Exhibits150: Paragon Biosciences LLC - Product / Service
• Exhibits151: Paragon Biosciences LLC - Key offerings
• Exhibits152: Questex LLC - Overview
• Exhibits153: Questex LLC - Product / Service
• Exhibits154: Questex LLC - Key offerings
• Exhibits155: Reviva Pharmaceuticals Holdings Inc - Overview
• Exhibits156: Reviva Pharmaceuticals Holdings Inc - Product / Service
• Exhibits157: Reviva Pharmaceuticals Holdings Inc - Key offerings
• Exhibits158: Sun Pharmaceutical Industries Ltd. - Overview
• Exhibits159: Sun Pharmaceutical Industries Ltd. - Product / Service
• Exhibits160: Sun Pharmaceutical Industries Ltd. - Key news
• Exhibits161: Sun Pharmaceutical Industries Ltd. - Key offerings
• Exhibits162: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibits163: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibits164: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibits165: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibits166: Teva Pharmaceutical Industries Ltd. - Segment focus
• Exhibits167: Inclusions checklist
• Exhibits168: Exclusions checklist
• Exhibits169: Currency conversion rates for US$
• Exhibits170: Research methodology
• Exhibits171: Information sources
• Exhibits172: Data validation
• Exhibits173: Validation techniques employed for market sizing
• Exhibits174: Data synthesis
• Exhibits175: 360 degree market analysis
• Exhibits176: List of abbreviations

The tourettes syndrome drugs market is forecasted to grow by USD 642.1 mn during 2023-2028, accelerating at a CAGR of 6.78% during the forecast period. The report on the tourettes syndrome drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing awareness about tourette syndrome, increasing cases of tourette syndrome across the world, and increasing demand for cost-effective treatments.

Technavio's tourettes syndrome drugs market is segmented as below:

By Product

• Antipsychotics
• Non-antipsychotics

By Distribution Channel

• Offline
• Online

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increasing r and d investments for tourette syndrome as one of the prime reasons driving the tourettes syndrome drugs market growth during the next few years. Also, rising strategic alliances among vendors and increasing healthcare infrastructure expenditure will lead to sizable demand in the market.

The report on the tourettes syndrome drugs market covers the following areas:

• Tourettes syndrome drugs market sizing
• Tourettes syndrome drugs market forecast
• Tourettes syndrome drugs market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading tourettes syndrome drugs market vendors that include AstraZeneca Plc, Bausch Health Companies Inc., Catalyst Pharmaceuticals Inc, Eli Lilly and Co., Emalex Biosciences Inc., H Lundbeck AS, Johnson and Johnson Services Inc., Medtronic Plc, Neurocrine Biosciences Inc., Otsuka Holdings Co. Ltd., Paragon Biosciences LLC, Questex LLC, Reviva Pharmaceuticals Holdings Inc, Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd.. Also, the tourettes syndrome drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 2.2 Market characteristics
  • Market characteristics analysis
• 2.3 Value chain analysis
  • Value Chain Analysis

3 Market Sizing

• 3.1 Market definition
  • Offerings of companies included in the market definition
• 3.2 Market segment analysis
  • Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global Tourettes Syndrome Drugs Market 2018 - 2022
  • Historic Market Size - Data Table on Global Tourettes Syndrome Drugs Market 2018 - 2022 ($ million)
• 4.2 Product segment analysis 2018 - 2022
  • Historic Market Size - Product Segment 2018 - 2022 ($ million)
• 4.3 Distribution Channel segment analysis 2018 - 2022
  • Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
• 4.4 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.5 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product

• 6.1 Market segments
  • Chart on Product - Market share 2023-2028 (%)
  • Data Table on Product - Market share 2023-2028 (%)
• 6.2 Comparison by Product
  • Chart on Comparison by Product
  • Data Table on Comparison by Product
• 6.3 Antipsychotics - Market size and forecast 2023-2028
  • Chart on Antipsychotics - Market size and forecast 2023-2028 ($ million)
  • Data Table on Antipsychotics - Market size and forecast 2023-2028 ($ million)
  • Chart on Antipsychotics - Year-over-year growth 2023-2028 (%)
  • Data Table on Antipsychotics - Year-over-year growth 2023-2028 (%)
• 6.4 Non-antipsychotics - Market size and forecast 2023-2028
  • Chart on Non-antipsychotics - Market size and forecast 2023-2028 ($ million)
  • Data Table on Non-antipsychotics - Market size and forecast 2023-2028 ($ million)
  • Chart on Non-antipsychotics - Year-over-year growth 2023-2028 (%)
  • Data Table on Non-antipsychotics - Year-over-year growth 2023-2028 (%)
• 6.5 Market opportunity by Product
  • Market opportunity by Product ($ million)
  • Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Distribution Channel

• 7.1 Market segments
  • Chart on Distribution Channel - Market share 2023-2028 (%)
  • Data Table on Distribution Channel - Market share 2023-2028 (%)
• 7.2 Comparison by Distribution Channel
  • Chart on Comparison by Distribution Channel
  • Data Table on Comparison by Distribution Channel
• 7.3 Offline - Market size and forecast 2023-2028
  • Chart on Offline - Market size and forecast 2023-2028 ($ million)
  • Data Table on Offline - Market size and forecast 2023-2028 ($ million)
  • Chart on Offline - Year-over-year growth 2023-2028 (%)
  • Data Table on Offline - Year-over-year growth 2023-2028 (%)
• 7.4 Online - Market size and forecast 2023-2028
  • Chart on Online - Market size and forecast 2023-2028 ($ million)
  • Data Table on Online - Market size and forecast 2023-2028 ($ million)
  • Chart on Online - Year-over-year growth 2023-2028 (%)
  • Data Table on Online - Year-over-year growth 2023-2028 (%)
• 7.5 Market opportunity by Distribution Channel
  • Market opportunity by Distribution Channel ($ million)
  • Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ million)
  • Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.9 UK - Market size and forecast 2023-2028
  • Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Chart on UK - Year-over-year growth 2023-2028 (%)
  • Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.10 China - Market size and forecast 2023-2028
  • Chart on China - Market size and forecast 2023-2028 ($ million)
  • Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Chart on China - Year-over-year growth 2023-2028 (%)
  • Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.11 Canada - Market size and forecast 2023-2028
  • Chart on Canada - Market size and forecast 2023-2028 ($ million)
  • Data Table on Canada - Market size and forecast 2023-2028 ($ million)
  • Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Data Table on Canada - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
• 10.4 Market opportunities/restraints

11 Competitive Landscape

• 11.1 Overview
• 11.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 11.3 Landscape disruption
  • Overview on factors of disruption
• 11.4 Industry risks
  • Impact of key risks on business

12 Competitive Analysis

• 12.1 Companies profiled
  • Companies covered
• 12.2 Market positioning of companies
  • Matrix on companies position and classification
• 12.3 AstraZeneca Plc
  • AstraZeneca Plc - Overview
  • AstraZeneca Plc - Product / Service
  • AstraZeneca Plc - Key news
  • AstraZeneca Plc - Key offerings
• 12.4 Bausch Health Companies Inc.
  • Bausch Health Companies Inc. - Overview
  • Bausch Health Companies Inc. - Business segments
  • Bausch Health Companies Inc. - Key news
  • Bausch Health Companies Inc. - Key offerings
  • Bausch Health Companies Inc. - Segment focus
• 12.5 Catalyst Pharmaceuticals Inc
  • Catalyst Pharmaceuticals Inc - Overview
  • Catalyst Pharmaceuticals Inc - Product / Service
  • Catalyst Pharmaceuticals Inc - Key offerings
• 12.6 Eli Lilly and Co.
  • Eli Lilly and Co. - Overview
  • Eli Lilly and Co. - Product / Service
  • Eli Lilly and Co. - Key news
  • Eli Lilly and Co. - Key offerings
• 12.7 Emalex Biosciences Inc.
  • Emalex Biosciences Inc. - Overview
  • Emalex Biosciences Inc. - Product / Service
  • Emalex Biosciences Inc. - Key offerings
• 12.8 H Lundbeck AS
  • H Lundbeck AS - Overview
  • H Lundbeck AS - Product / Service
  • H Lundbeck AS - Key offerings
• 12.9 Johnson and Johnson Services Inc.
  • Johnson and Johnson Services Inc. - Overview
  • Johnson and Johnson Services Inc. - Business segments
  • Johnson and Johnson Services Inc. - Key news
  • Johnson and Johnson Services Inc. - Key offerings
  • Johnson and Johnson Services Inc. - Segment focus
• 12.10 Medtronic Plc
  • Medtronic Plc - Overview
  • Medtronic Plc - Business segments
  • Medtronic Plc - Key news
  • Medtronic Plc - Key offerings
  • Medtronic Plc - Segment focus
• 12.11 Neurocrine Biosciences Inc.
  • Neurocrine Biosciences Inc. - Overview
  • Neurocrine Biosciences Inc. - Product / Service
  • Neurocrine Biosciences Inc. - Key offerings
• 12.12 Otsuka Holdings Co. Ltd.
  • Otsuka Holdings Co. Ltd. - Overview
  • Otsuka Holdings Co. Ltd. - Business segments
  • Otsuka Holdings Co. Ltd. - Key news
  • Otsuka Holdings Co. Ltd. - Key offerings
  • Otsuka Holdings Co. Ltd. - Segment focus
• 12.13 Paragon Biosciences LLC
  • Paragon Biosciences LLC - Overview
  • Paragon Biosciences LLC - Product / Service
  • Paragon Biosciences LLC - Key offerings
• 12.14 Questex LLC
  • Questex LLC - Overview
  • Questex LLC - Product / Service
  • Questex LLC - Key offerings
• 12.15 Reviva Pharmaceuticals Holdings Inc
  • Reviva Pharmaceuticals Holdings Inc - Overview
  • Reviva Pharmaceuticals Holdings Inc - Product / Service
  • Reviva Pharmaceuticals Holdings Inc - Key offerings
• 12.16 Sun Pharmaceutical Industries Ltd.
  • Sun Pharmaceutical Industries Ltd. - Overview
  • Sun Pharmaceutical Industries Ltd. - Product / Service
  • Sun Pharmaceutical Industries Ltd. - Key news
  • Sun Pharmaceutical Industries Ltd. - Key offerings
• 12.17 Teva Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd. - Overview
  • Teva Pharmaceutical Industries Ltd. - Business segments
  • Teva Pharmaceutical Industries Ltd. - Key news
  • Teva Pharmaceutical Industries Ltd. - Key offerings
  • Teva Pharmaceutical Industries Ltd. - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 13.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 13.4 Research methodology
  • Research methodology
• 13.5 Data procurement
  • Information sources
• 13.6 Data validation
  • Data validation
• 13.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 13.8 Data synthesis
  • Data synthesis
• 13.9 360 degree market analysis
  • 360 degree market analysis
• 13.10 List of abbreviations
  • List of abbreviations